BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Biomedical Technologies Incorporated

Below is an extended Biomedical Technologies Incorporated research listing. Click here to return to the Biomedical Technologies Incorporated main Biocorporate entry.

Recent Publications by Biomedical Technologies Incorporated:

High-Throughput Multiplex HLA-Typing by Ligase Detection Reaction (LDR) and Universal Array (UA) Approach.
One major goal of genetic research is to understand the role of genetic...
8th October, 2008
Institute for Biomedical Technologies, National Research Council, Milano, Methods Mol Biol. 2009;496:115-27.
DOI Direct Link
A parallel protein surface reconstruction system.
In this paper we propose a parallel system for protein surface...
8th October, 2008
Institute for Biomedical Technologies, National Research Council, Segrate Int J Bioinform Res Appl. 2008;4(3):221-39.
Cochlear repair by transplantation of human cord blood CD133+ cells to nod-scid mice made deaf with kanamycin and noise.
We investigated the fate of human cord blood CD133+ hematopoietic stem...
30th September, 2008
Foundation onlus Staminali e Vita, Institute of Biomedical Technologies, Cell Transplant. 2008;17(6):665-78.
PA.NET International Quality Certification Protocol for blood pressure monitors.
Although standard validation protocols provide assurance of the accuracy...
19th September, 2008
aARSMED (Association for Research and Development of Biomedical Blood Press Monit. 2008 Oct;13(5):285-289.
DOI Direct Link
Large-scale brain networks account for sustained and transient activity during target detection.
Target detection paradigms have been widely applied in the study of human...
17th September, 2008
Institute for Advanced Biomedical Technologies, "G. D'Annunzio University" Neuroimage. 2008 Aug 28.
DOI Direct Link
Aluminum Modulates Effects of betaAmyloid(142) on Neuronal Calcium Homeostasis and Mitochondria Functioning and Is Altered in a Triple Transgenic Mouse Model of Alzheimer's Disease.
Recent findings suggest that beta-amyloid (Abeta) is more neurotoxic when...
16th September, 2008
CNR-Institute for Biomedical Technologies, Padua "Metalloproteins" Unit, Rejuvenation Res. 2008 Sep 12.
DOI Direct Link
Neuromelanin can protect against iron-mediated oxidative damage in system modeling iron overload of brain aging and Parkinson's disease.
In Parkinson's disease (PD), dopamine neurons containing neuromelanin...
16th September, 2008
Institute of Biomedical Technologies - Italian National Research Council, J Neurochem. 2008 Aug;106(4):1866-75. Epub 2008 Jul 4.
DOI Direct Link
The role of growth factors in the prevention and treatment of chemotherapy-induced peripheral neurotoxicity.
Chemotherapy-induced peripheral neurotoxicity (CIPN) is a major clinical...
3rd September, 2008
Department of Neuroscience and Biomedical Technologies, University of Curr Drug Saf. 2006 Jan;1(1):35-42.
Helping young independent scientists: the EMBO Young Investigator Programme Interview with Gerlind Wallon, Deputy Executive Director, EMBO Young Investigator Programme.
Recent findings suggest that beta-amyloid (Abeta) is more neurotoxic when...
30th August, 2008
ITB - Institute for Biomedical Technologies, Italian National Council of N Biotechnol. 2008 Aug 19.
DOI Direct Link
Executive functions with different motor outputs in somatosensory Go/Nogo tasks: An event-related functional MRI study.
The aim of this event-related functional magnetic resonance imaging (fMRI)...
30th August, 2008
ITAB-Institute for Advanced Biomedical Technologies, Gabriele D'Annunzio Brain Res Bull. 2008 Aug 20.
DOI Direct Link
Mutual Stimulation of Beta-Amyloid Fibrillogenesis by Clioquinol and Divalent Metals.
As reported by some authors, clioquinol (CQ), a 8-hydroxyquinoline...
21st August, 2008
Department of Biology, Padova "Metalloproteins" Unit, CNR-Institute of Neuromolecular Med. 2008 Aug 19.
DOI Direct Link
A DIGE approach for the assessment of rat soleus muscle changes during unloading: effect of acetyl-L-carnitine supplementation.
After hind limb suspension, a remodeling of postural muscle phenotype is...
8th August, 2008
Department of Sciences and Biomedical Technologies, University of Milan, Proteomics. 2008 Sep;8(17):3588-604.
DOI Direct Link
Lymphomonocyte alpha-synuclein levels in aging and in Parkinson disease.
In this study we employed an ELISA assay to measure alpha-synuclein...
5th August, 2008
Laboratory of Neurobiology, Department of Neuroscience and Biomedical Neurobiol Aging. 2008 Aug 2.
DOI Direct Link
Increased oxidative stress in lymphocytes from untreated Parkinson's disease patients.
In this paper we propose a parallel system for protein surface...
22nd July, 2008
Laboratory of Neurobiology, Department of Neuroscience and Biomedical Parkinsonism Relat Disord. 2008 Jul 17.
DOI Direct Link
Antioxidants partially restore glutamate transport defect in leber hereditary optic neuropathy cybrids.
Leber hereditary optic neuropathy (LHON) is a mitochondrial disease...
11th July, 2008
Department of Neuroscience and Biomedical Technologies, University of J Neurosci Res. 2008 Jul 9.
DOI Direct Link

«Biomedical Technologies Incorporated

This page contained an extended Biomedical Technologies Incorporated research listing. Click here to return to the Biomedical Technologies Incorporated main Biocorporate entry.

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.